Is Sotolaxib covered by medical insurance reimbursement? Medical insurance policy and 2025 updates

Sotorasib (AMG510, Sotorasib) is a new type of targeted drug specifically used to treat patients with non-small cell lung cancer (NSCLC) and colorectal cancer (mCRC) carrying KRAS G12C mutations. This mutation is relatively common in lung cancer, and traditional treatments are not very effective. The emergence of sotoracib provides a new treatment option for this specific group of people. It inhibits the activity of KRAS G12C mutant to prevent the proliferation and spread of cancer cells, thereby improving patient prognosis.

At present, the original drug of sotorasibu is not yet on the market in China, so patients cannot obtain the drug through formal domestic channels. At the same time, this drug is not included in the scope of medical insurance reimbursement, which makes many patients face a high financial burden. It is understood that the drug has been sold in Hong Kong and other regions.The price of 120mg*240 tablets is about RMB 80,000. This price may change due to exchange rate fluctuations. In Europe, the price of drugs of the same specifications is more than 40,000 yuan. Compared with the domestic market, the price in Europe is slightly lower.

For Chinese patients, the lack of medical insurance support limits the accessibility of sotoraxib, especially in terms of treatment costs. Although there are some online channels in China where the drug can be purchased, due to the lack of supervision, patients need to be extra cautious when purchasing to ensure that they are getting genuine products. At the same time, there are also generic drugs on the market, such as 120mg*56 tablets produced by Lucius Pharmaceutical Factory in Laos, and the price is about more than 1,000 yuan. Although the ingredients of generic drugs are similar to the original drugs, there may be differences in quality and efficacy. Therefore, patients must consult a professional doctor when choosing to ensure the safety and effectiveness of use.

Reference materials:https://www.lumakras.com/